The authors would like to make the following corrections to this paper [1]:
1. Change in Equation (1)
We have found two typographical errors in Equation (1) and we wish to replace
With
2. Change in Table 2
Table 2.
Test Compound | Peff (×10−5 cm/s) | Papp (×10−6 cm/s) |
---|---|---|
OLC | 2.23 ± 3.16 | 4.12 * ± 2.33 |
LEV | 7.64 ± 5.55 | 10.91 ± 6.27 |
* p < 0.05, Mann-Whitney U-test.
We have found a typographical error in the Peff heading in Table 2. In addition, and after reviewing the calculations again, we have detected that the data shown in Table 2 for levofloxacin did not consider the normalization of the 10-cm intestinal segment. With the normalization, the Peff value for levofloxacin increases (according to the length of the intestinal segment used). For these reasons, the authors wish to replace
With
Table 2.
Test Compound | Peff (×10−4 cm/s) | Papp (×10−6 cm/s) |
---|---|---|
OLC | 2.85 ± 2.63 | 4.12 * ± 2.33 |
LEV | 12.69 ± 6.64 | 10.91 ± 6.27 |
* p < 0.05, Mann–Whitney U-test.
These changes do not affect the discussion and conclusions of the study. The authors would like to apologize for any inconvenience caused to the readers by these changes.
Conflicts of Interest
R.M.L.-R. reports receiving lecture fees from Cerveceros de España and receiving lecture fees and travel support from Adventia. The other authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.López-Yerena A., Vallverdú-Queralt A., Mols R., Augustijns P., Lamuela-Raventós R.M., Escribano-Ferrer E. Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats. Pharmaceutics. 2020;12:134. doi: 10.3390/pharmaceutics12020134. [DOI] [Google Scholar]